Company Filing History:
8 out of 15,488 
2 out of 2 
3 out of 832,891 Years Active: 1993-2023
Title: Innovations of Maurizio Zanetti in Cancer Treatment
Introduction
Maurizio Zanetti is a prominent inventor based in La Jolla, California, known for his significant contributions to the field of cancer research. With a total of 13 patents to his name, he has developed groundbreaking technologies aimed at improving cancer treatment and prevention.
Latest Patents
Among his latest patents is the development of engineered B lymphocytes and compositions having micro-RNA. This innovation involves modifying B lymphocytes to express various types of microRNAs or anti-miRs, which can be used to treat or prevent cancer, particularly breast cancer. His work includes methods for treating inflammation and diseases by administering B lymphocytes that secrete microRNAs or anti-miRs. Another notable patent is the universal cancer vaccine, which comprises altered human telomerase polypeptides designed to enhance immunogenicity. This vaccine aims to provide a new approach to treating individuals afflicted with or at risk of developing cancer.
Career Highlights
Zanetti has worked with esteemed institutions, including the University of California, where he has contributed to significant advancements in cancer research. His innovative approaches have positioned him as a leader in the field, focusing on the intersection of immunology and oncology.
Collaborations
Throughout his career, Zanetti has collaborated with notable colleagues such as Petar Lenert and Edward Golub. These partnerships have fostered a collaborative environment that enhances the development of innovative cancer therapies.
Conclusion
Maurizio Zanetti's work exemplifies the potential of innovative research in transforming cancer treatment. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.